Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maison Royer is a French biotechnology and skincare company that specializes in the extraction and application of organic snail mucin for dermatological health. Founded in 1989, the company utilizes a proprietary, non-lethal cold extraction process to harvest high-purity snail slime rich in bioactive compounds such as allantoin, collagen, and elastin. Their product range, marketed under the Royer Cosmétique brand, is designed to treat various skin conditions including acne, eczema, and signs of aging. The company operates a vertically integrated facility in Vendée, France, encompassing snail farming, laboratory research, and manufacturing. Maison Royer is distinguished by its commitment to organic certification and animal welfare, positioning itself as a leader in the natural bioactive skincare market. The company's research focuses on the regenerative properties of snail mucin for human skin repair and maintenance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maison Royer.